SpinChem’s rotating bed reactor (RBR) technology is already deployed in more than 40 countries. Strengthened by the new EU–India Free Trade Agreement, the company is now expanding its presence in one of the world’s fastest-growing pharmaceutical markets through a partnership with Smart Labtech Private Ltd.
Umeå‑based Direkttest specializes in digital self‑sampling solutions, and continues its upward trajectory after its pandemic breakthrough. With a major new Swedish research contract secured and active discussions about expanding into the United Arab Emirates, the firm is now taking decisive steps toward both national and international growth.
The UBI company Nil Medical AB has been selected as a finalist in this year’s Medtech4Health Innovation Award for the Vestpack, a solution designed to make everyday life easier for children and young people undergoing medical treatment.
SpinChem AB has been certified according to ISO 9001:2015 by RISE, covering the company’s development, production, and delivery of rotating bed reactor (RBR) systems for advanced fluid processing.
Boreal Orchards is taking the next step in ecosystem restoration. With support from Vinnova (Sweden’s Innovation Agency) and industry partners, the company will develop methods to restore reindeer lichen in disturbed mining landscapes. The four-year project, ”symbios”, is funded with a total of SEK 15.5 million and brings together eight partners – including a Canadian mining company and the Swedish Sami Association.
Diamyd Medical has expanded its manufacturing strategy through a long‑term collaboration with APL in Umeå and a strategic partnership with NorthX Biologics, a contract development and manufacturing organisation (CDMO) based in Matfors, Sweden. Together, the parties will further develop and scale up production of the biological drug candidate retogatein (rhGAD65) in preparation for potential future commercialisation.
Umeå-based Nil Medical was one of eleven Nordic HealthTech companies chosen for the Propel International Boot Camp – an accelerator programme in the Yorkshire and Humber region of the United Kingdom. The boot camp was designed to provide a faster route into the UK market and offer expert support on the British healthcare system, legal frameworks, funding, networking and market growth.
METTLER TOLEDO has joined Umeå Biotech Incubutor (UBI) as a Lab Sponsor and has equipped the UBI laboratory with a RAININ SmartCheck.
Umeå Biotech Incubator växer nu med en ny Affärscoach för ett vikariat till och med 15 december 2026 – är du den?
Three researchers at Umeå University and one at the Swedish University of Agricultural Sciences (SLU) have been granted funding through Umeå Biotech Incubator’s (UBI) call “Pre‑Incubator Funding for Critical Experiments in Life Science.” The program targets researchers preparing to conduct decisive experiments that can validate or de‑risk early-stage innovation projects.
Mucocort AB today announced that the company has received a notice of approval for a Swedish patent covering the antimicrobial mechanism of action in its innovative treatment patch, M045A, developed for the treatment of oral ulcers caused by aphthae (Recurrent Aphthous Stomatitis).
It began as a spin-off from Umeå University. Ten years later, Prediktera is a global player in hyperspectral image analysis – and is now celebrating its 10th anniversary.
SpinChem, based in Umeå, Sweden, has developed the SpinChem® MiniRBR — a refillable, milliliter-scale rotating bed reactor designed for rapid screening and reliable scale-up in biocatalysis and solid–liquid processes. Operating from just 5 mL, the MiniRBR enables fast parallel testing, reduced work-up, and enhanced mass transfer that closely mirrors the performance of larger RBR systems.
The UBI Alumni MetaCurUm AB has been awarded 1 million SEK in the second phase of Vinnova’s initiative “Acceleration of Deep Tech Companies”. The support will enable MetaCurUm to progress its innovative cancer therapy toward preclinical and future clinical studies.
Umeå-based agtech innovator Cropcision is strengthening its leadership team as it enters a new growth phase. Jonas Gullberg will lead the launch and market introduction of SILVIVO, the company’s first product for the forestry sector.
A research team from Umeå and Uppsala university led by Maréne Landström, founder of UBI-supported MetaCurUm Biotech, has identified a panel of seven blood-based protein biomarkers that can accurately detect clear cell renal cell carcinoma (ccRCC), the most common and aggressive form of kidney cancer.
An unexpected collaboration between professor Magnus Wolf-Watz at Umeå University and the biotech company Vakona is a prime example of how fundamental research can gain new relevance and impact. By combining academic curiosity with industrial application, the project has led to technological breakthroughs and new research — while also contributing to societal benefit in form of acne treatment.
RegenCura strengthens its team to accelerate regulatory development and hires chemist Björn Greijer.
Nil Medical AB has received its first external investment – from Barncancerfonden Impact Invest AB, a newly established impact venture launched by the Swedish Childhood Cancer Fund.
“A perfect match for us. The mission of Barncancerfonden Impact Invest aligns perfectly with our values: ensuring that any potential profit contributes to future patient benefit and supports continued research and innovation,” says Martin Hanberger, CEO and founder of Nil Medical AB.
Nil Medical AB is currently seeking a Sales Manager to support its continued growth and international expansion. The ideal candidate will bring global experience from the medical technology sector and play a key role in building the company’s commercial organization.